Literature DB >> 19530952

Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors.

Nancy Crum-Cianflone1, Jhamillia Weekes, Mary Bavaro.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are well described among the general population, but little is known regarding the incidence of and predictors for recurrent CA-MRSA infections among HIV-infected persons. We retrospectively evaluated HIV-infected patients seen at the Naval Medical Center San Diego from January 1, 2000 to June 30, 2007 for wound culture-proven MRSA infections defined as community-associated based on Centers for Disease Control and Prevention (CDC) criteria. Data on skin/soft tissue infections (SSTIs) following an initial CA-MRSA infection were collected by review of medical records and culture results. Patients with or without recurrent infections were compared for predictors of recurrence using multivariate logistic regression models. Thirty-one (6.8%) of 458 patients with HIV had wound culture-proven CA-MRSA SSTIs for an incidence rate of 12.3 infections per 1000 person-years. Those who developed a MRSA infection had a mean age of 40 years, 97% were male, 58% were Caucasian, 23% were Hispanic, 16% were African American, and 3% were other; demographics were similar to the overall study population. Fourteen (41%) HIV patients with an initial MRSA infection had recurrent SSTIs; of these, seven (21%) had culture-confirmed recurrent CA-MRSA. The median time between infection recurrences was 4 months (range, 1-20 months). Suppressed HIV-1 RNA levels of less than 1000 copies per milliliter (odds ratio [OR] 0.14, p = 0.03) was associated with a lower rate of SSTI recurrence. In summary, HIV-infected persons have a high incidence of CA-MRSA skin/soft tissue infections and a high rate of recurrence. HIV control may be associated with a reduced risk of recurrent skin/soft tissue infections.

Entities:  

Mesh:

Year:  2009        PMID: 19530952      PMCID: PMC2732573          DOI: 10.1089/apc.2008.0240

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  17 in total

1.  A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Evan J Anderson; Claudia Hawkins; Maureen K Bolon; Frank J Palella
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

2.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity.

Authors:  Erica S Pan; Binh An Diep; Edwin D Charlebois; Colette Auerswald; Heather A Carleton; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  J Infect Dis       Date:  2005-08-02       Impact factor: 5.226

4.  Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults.

Authors:  Wm Christopher Mathews; Joseph C Caperna; R Edward Barber; Francesca J Torriani; Loren G Miller; Susanne May; J Allen McCutchan
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

5.  Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men.

Authors:  Nolan E Lee; Melanie M Taylor; Elizabeth Bancroft; Peter J Ruane; Margie Morgan; Lucie McCoy; Paul A Simon
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

6.  Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage.

Authors:  Alicia I Hidron; Ekaterina V Kourbatova; J Sue Halvosa; Bianca J Terrell; Linda K McDougal; Fred C Tenover; Henry M Blumberg; Mark D King
Journal:  Clin Infect Dis       Date:  2005-06-08       Impact factor: 9.079

Review 7.  Community-associated methicillin-resistant Staphylococcus aureus.

Authors:  J Todd Weber
Journal:  Clin Infect Dis       Date:  2005-08-15       Impact factor: 9.079

8.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

9.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

10.  Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients.

Authors:  Mary Jo Cenizal; Robert D Hardy; Marc Anderson; Kathy Katz; Daniel J Skiest
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

View more
  23 in total

Review 1.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

2.  Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections.

Authors:  Samantha J Eells; Megan Nguyen; Jina Jung; Raul Macias-Gil; Larissa May; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort.

Authors:  Jason E Farley; Matthew J Hayat; Paul L Sacamano; Tracy Ross; Karen Carroll
Journal:  Am J Infect Control       Date:  2015-02-14       Impact factor: 2.918

4.  The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.

Authors:  Rachel J Gordon; Nancy Chez; Haomiao Jia; Barbara Zeller; Magda Sobieszczyk; Caitlin Brennan; Katherine B Hisert; Mei-Ho Lee; Peter Vavagiakis; Franklin D Lowy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 5.  Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections.

Authors:  Joshua D Milner; Netanya G Sandler; Daniel C Douek
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

6.  Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Authors:  David Skurnik; Massimo Merighi; Martha Grout; Mihaela Gadjeva; Tomas Maira-Litran; Maria Ericsson; Donald A Goldmann; Susan S Huang; Rupak Datta; Jean C Lee; Gerald B Pier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

Review 7.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 8.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

9.  Revisiting Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  Abdelkarim Waness
Journal:  J Glob Infect Dis       Date:  2010-01

10.  Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era.

Authors:  V Hemmige; M McNulty; E Silverman; M Z David
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.